228 related articles for article (PubMed ID: 14762289)
1. Designing clinical development programs for anti-hepatitis B virus drugs.
Brown NA
Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
[No Abstract] [Full Text] [Related]
2. Chronic hepatitis B: back to the future with HBsAg.
Moucari R; Lada O; Marcellin P
Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
[No Abstract] [Full Text] [Related]
3. Transmission of antiviral drug resistant hepatitis B virus: implications for public health and patient management.
Locarnini S
J Gastroenterol Hepatol; 2010 Apr; 25(4):649-51. PubMed ID: 20492319
[No Abstract] [Full Text] [Related]
4. [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
Liu L; Tang YZ; Li JG; Zhou JJ; Wang XH; Wang YM
Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):423-7. PubMed ID: 20587311
[TBL] [Abstract][Full Text] [Related]
5. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Wiegand J; Hasenclever D; Tillmann HL
Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
[TBL] [Abstract][Full Text] [Related]
6. [Lamivudine treatment consensus from relative experts].
Lamivudine Clinical Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391
[No Abstract] [Full Text] [Related]
7. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
8. Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
Koike K
J Gastroenterol; 2002; 37(11):988-90. PubMed ID: 12483259
[No Abstract] [Full Text] [Related]
9. [Treatment of hepatitis B].
Telegdy L
Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B viral mutation and its clinical significance].
Asahina Y; Izumi N
Nihon Rinsho; 2004 Aug; 62 Suppl 8():167-74. PubMed ID: 15453309
[No Abstract] [Full Text] [Related]
11. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
[TBL] [Abstract][Full Text] [Related]
12. [Lamivudine treatment for hepatitis B].
Lamivudine Clincal Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
[No Abstract] [Full Text] [Related]
13. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
14. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
15. Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
Angus P; Locarnini S
Antivir Ther; 2004 Apr; 9(2):145-8. PubMed ID: 15134176
[No Abstract] [Full Text] [Related]
16. [Introduction to chronic hepatitis type B].
Inoue O; Nakagawa Y; Mawatari H
Nihon Rinsho; 2004 Aug; 62 Suppl 8():285-9. PubMed ID: 15453331
[No Abstract] [Full Text] [Related]
17. [Advance in clinical studies of the kinetics of hepatitis B virus].
Tang YT; Cao Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
[No Abstract] [Full Text] [Related]
18. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
Suzuki F; Akuta N; Suzuki Y; Sezaki H; Arase Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Watahiki S; Kumada H
J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
Kumar M; Sarin SK
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
[TBL] [Abstract][Full Text] [Related]
20. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
